IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROZZINI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.950
EU - Europa 2.788
AS - Asia 1.617
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
OC - Oceania 5
Totale 10.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.923
CN - Cina 869
UA - Ucraina 832
PL - Polonia 505
DE - Germania 402
SG - Singapore 323
IT - Italia 318
HK - Hong Kong 205
FI - Finlandia 196
GB - Regno Unito 124
IE - Irlanda 118
RU - Federazione Russa 117
TR - Turchia 111
FR - Francia 104
IN - India 47
VN - Vietnam 22
BE - Belgio 19
CA - Canada 18
IR - Iran 17
SE - Svezia 14
MX - Messico 8
CZ - Repubblica Ceca 7
EU - Europa 7
ID - Indonesia 6
AU - Australia 5
JP - Giappone 5
KR - Corea 5
NL - Olanda 5
AT - Austria 4
HU - Ungheria 4
CH - Svizzera 3
ES - Italia 3
MU - Mauritius 3
BR - Brasile 2
BY - Bielorussia 2
CL - Cile 2
LV - Lettonia 2
MY - Malesia 2
SI - Slovenia 2
TW - Taiwan 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
LT - Lituania 1
MA - Marocco 1
RO - Romania 1
SM - San Marino 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 10.381
Salva come PNG Salva come JPEG
Città #
Fairfield 974
Woodbridge 791
Jacksonville 555
Warsaw 505
Houston 498
Ashburn 414
Wilmington 375
Cambridge 363
Seattle 357
Ann Arbor 305
Singapore 269
Princeton 221
Nanjing 217
Chandler 208
Hong Kong 204
Beijing 135
Dublin 118
Brescia 110
New York 105
Istanbul 102
Helsinki 96
Nanchang 72
Hebei 55
Munich 48
Moscow 47
San Diego 45
Dearborn 44
Des Moines 41
Changsha 39
Milan 38
Shenyang 38
Jinan 37
Tianjin 37
Shanghai 34
Jiaxing 26
Dong Ket 22
Kunming 22
Hangzhou 21
Verona 20
Brussels 19
Toronto 17
San Francisco 16
San Mateo 16
Ningbo 15
Augusta 14
Boardman 14
Lanzhou 14
Ardabil 13
Haikou 10
Leawood 10
London 10
Zhengzhou 10
Guangzhou 9
Los Angeles 9
Mumbai 8
Norwalk 8
Falkenstein 7
Monmouth Junction 7
Auburn Hills 6
Jakarta 6
Taizhou 6
Lancaster 5
Taiyuan 5
Ancona 4
Bologna 4
Ciudad Nezahualcoyotl 4
Como 4
Kilburn 4
Kocaeli 4
Nürnberg 4
Phoenix 4
Rome 4
Salina Cruz 4
Venezia 4
Washington 4
Bangalore 3
Brno 3
Canberra 3
Castelraimondo 3
Changchun 3
Cremona 3
Fuzhou 3
Gwanak-gu 3
Olomouc 3
Palermo 3
Redwood City 3
Shaoxing 3
Szeged 3
Vicenza 3
Castelnuovo 2
Cavallino 2
Chiswick 2
Frankfurt am Main 2
Hounslow 2
Indiana 2
Lappeenranta 2
Lodi 2
Mantova 2
Minsk 2
Montichiari 2
Totale 7.974
Salva come PNG Salva come JPEG
Nome #
Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. 263
Gene expression profile in fibroblasts of Huntington's disease patients and controls 220
Behavioral disorders in Alzheimer disease: a transcultural perspective 218
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. 208
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 167
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 164
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 160
Gene expression profile in fibroblasts of Huntington's disease patients and controls. 154
The Italian version of the pain assessment in advanced dementia (PAINAD) scale 153
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 148
COVID-19 impact on consecutive neurological patients admitted to the emergency department 148
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 147
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 146
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 138
A case report: doctor, my daughter has Alzheimer's disease. 129
Alzheimer disease and frontotemporal dementia. 127
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 127
Procedural memory stimulation in Alzheimer's disease: impact of a training programme. 125
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 124
Gene expression profile in fibroblasts of Huntington's disease patients and controls 122
Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. 121
Predictors of progression from mild cognitive impairment to Alzheimer disease. 121
Cognitive dysfunction and age-related macular degeneration. 117
Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease. 116
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 116
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. 113
Behavioral syndromes in Alzheimer's disease: description and correlates. 111
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease. 111
Depressive disorders in dementia. 110
Diagnosis disclosure and advance care planning in Alzheimer disease: opinions of a sample of Italian citizens. 108
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 106
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 106
Do vascular risk factors play a role in the progression of mild cognitive impairment? 106
Anxiety symptoms in mild cognitive impairment. 105
Does reversible MCI exist? 105
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 105
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 104
Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. 104
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 103
Does age at observation time affect the clinical presentation of mild cognitive impairment? 103
Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. 102
Surface dyslexia in an Italian patient with semantic dementia 98
The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia due to Alzheimer's Disease in Routine Clinical Practice 98
Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. 97
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 97
The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. 96
Object and action naming in Alzheimer's disease and frontotemporal dementia 96
Microvascular damage and platelet abnormalities in early Alzheimer's disease. 96
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study 96
Free copper in serum: An analytical challenge and its possible applications 96
Pre-stroke and post-stroke dementia: Preliminary data from an Italian study 94
Prestroke dementia: characteristics and clinical features in consecutive series of patients. 94
Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. 93
The migraine-PFO connection is independent of sex. 92
Transient global amnesia and venous flow patterns. 91
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease. 91
Severe worsening of parkinsonism in Lewy body dementia due to donepezil. 91
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment 90
Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. 89
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 89
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. 88
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. 88
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease 88
Transient global amnesia and disturbance of venous flow patterns 87
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study. 87
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 86
Transient global amnesia: a clinical and sonographic study 85
Parkinsonian signs in subjects with mild cognitive impairment 82
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. 82
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 82
Spatial navigation in elderly healthy subjects, amnestic and non amnestic MCI patients 82
The impact of cognitive deficit on self-reported car crashes in ultra-octogenarian population: data of an Italian population-based study. 81
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study. 81
Depression is unrelated to conversion to dementia in patients with mild cognitive impairment. 79
Predictors of institutionalization in demented patients discharged from a rehabilitation unit 75
Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study 74
Changes in characteristics of Alzheimer patients at first visit to centers for dementia: a 10-year follow-up study. 74
Alteration of APP processing in platelets and CSF of AD patients European 68
Assessment of platelet Amyloid Precursor Protein forms ratio in patients with mild cognitive impairment: A tool for the identification of preclinical Alzheimer Disease 68
Acetylcholinestfrase inhibitors are effective in "real world" patients with mild to moderate Alzheimer disease: Evidence from a large population treated with rivastigmine or donepezil 67
Volume reduction in cerebral blood flow in patients with Alzheimer’s disease. A sonographic study 66
Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. 65
App isoforms ratio in platelets: A peripheral marker for the diagnosis and treatment of Alzheimer's disease? 62
Efficacy of SSRI on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors 60
Apolipoprotein E allele and platelets amyloid precursor protein in Alzheimer's disease: Biological effect of acetylcholinesterase inhibitors treatment 60
Knowledge and attitudes about Alzheimer's disease in the lay public: influence of caregiving experience and other socio-demographic factors in an Italian sample. 56
Clinical correlates of executive dysfunctions in mild cognitive impairment 56
Retrograde jugular venous flow is a predisposing factor in transient global amnesia. 54
Aspetti etici delle demenze 54
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 54
Vascular risk factors for VaD and AD in a population-based prospective cohort. The PAQUID study 52
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 52
Hypercholesterolaemia increases platelet amyloid precusor protein processing impairment in Alzheimer's disease patients 52
Short-term memory binding in mild cognitive impairment: a preclinical marker of Alzheimer's disease? 51
Rehabilitation units for people suffering dementia. Reports on the development process for providing a model of care 50
Microvascular damage and platelet abnormalities in early Alzheimer's diseases 49
Il progetto Cronos e le Unità di Valutazione Alzheime 49
Predictors of recurence in paradoxical cerebral embolism 49
Differences in detecting symptoms of osteoarthritis in patients with cognitive impairment in two geriatric settings 49
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 49
Totale 9.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.311
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.765 0 0 0 0 0 318 282 336 206 328 132 163
2020/20211.987 47 275 81 192 129 242 76 250 210 172 242 71
2021/2022859 39 198 9 39 7 36 53 56 50 101 55 216
2022/2023691 129 21 12 35 65 207 6 61 91 4 25 35
2023/2024740 48 25 73 43 21 123 29 26 213 13 9 117
2024/2025719 10 22 22 268 239 158 0 0 0 0 0 0
Totale 10.552